SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
99 hedge funds and large institutions have $560M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 26 closing their positions.
28% more capital invested
Capital invested by funds: $436M → $560M (+$124M)
9% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 33
4% less funds holding
Funds holding: 103 → 99 (-4)
15% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$15.3M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$12.9M |
| 3 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$11.5M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$11.5M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$20.7M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$13.8M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$9.55M |
| 4 |
JP Morgan Chase
New York
|
-$7.2M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.76M |
SGNT Hedge Fund Activity: Q4 2013 in Review
99 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2013, worth a combined $560M — up 28% from $436M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SGNT and 22 opened new positions — a net loss of 4 holders — while 33 trimmed existing stakes and 36 added.
The largest buyer was NWQ Investment Management Company, opening a new position worth an estimated $15.3M. The largest seller was Deerfield Management, exiting entirely with an estimated $20.7M sold.
- 99 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2013, down from 103 in Q3 2013.
- Funds reported $560M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2013, up 28% quarter-over-quarter.
- 22 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2013 and 26 closed out, a net change of -4 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2013 was NWQ Investment Management Company, an estimated $15.3M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2013 was Deerfield Management, an estimated $20.7M sold.
Based on aggregated 13F filings for Q4 2013.